🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 10 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 09/09/2024 | 101,54 | 103,81 | 101,42 | 102,78 | +1,62% | 2,35% | 76.800 |
| 06/09/2024 | 103,58 | 104,89 | 99,08 | 101,14 | -1,95% | 5,61% | 64.700 |
| 05/09/2024 | 101,98 | 103,93 | 101,80 | 103,15 | +0,58% | 2,09% | 82.600 |
| 04/09/2024 | 100,44 | 103,04 | 98,89 | 102,56 | +1,59% | 4,13% | 119.600 |
| 03/09/2024 | 105,08 | 106,42 | 100,18 | 100,95 | -4,58% | 5,94% | 105.800 |
| 30/08/2024 | 106,00 | 106,16 | 102,60 | 105,80 | -0,06% | 3,36% | 113.900 |
| 29/08/2024 | 106,75 | 108,83 | 105,55 | 105,86 | -0,64% | 3,07% | 82.800 |
| 28/08/2024 | 105,99 | 107,65 | 103,50 | 106,54 | +0,20% | 3,92% | 152.500 |
| 27/08/2024 | 104,58 | 106,48 | 104,50 | 106,33 | +1,07% | 1,89% | 160.300 |
| 26/08/2024 | 104,07 | 106,99 | 103,94 | 105,20 | +1,33% | 2,93% | 120.500 |
| 23/08/2024 | 103,81 | 105,50 | 103,39 | 103,82 | +0,19% | 2,03% | 69.700 |
| 22/08/2024 | 106,25 | 106,25 | 103,21 | 103,62 | -2,32% | 2,86% | 66.900 |
| 21/08/2024 | 105,00 | 106,84 | 102,87 | 106,08 | +1,67% | 3,78% | 121.900 |
| 20/08/2024 | 103,00 | 104,73 | 101,88 | 104,34 | +0,72% | 2,77% | 100.400 |
| 19/08/2024 | 102,00 | 103,75 | 101,11 | 103,59 | +1,35% | 2,59% | 98.800 |
| 16/08/2024 | 103,27 | 104,28 | 102,20 | 102,21 | -0,89% | 2,01% | 97.100 |
| 15/08/2024 | 102,93 | 106,75 | 102,69 | 103,13 | +2,09% | 3,94% | 148.100 |
| 14/08/2024 | 102,62 | 103,88 | 101,00 | 101,02 | -1,94% | 2,81% | 95.700 |
| 13/08/2024 | 100,10 | 103,04 | 99,15 | 103,02 | +3,43% | 3,89% | 203.800 |
| 12/08/2024 | 103,28 | 103,28 | 98,71 | 99,60 | -0,56% | 4,42% | 114.000 |
| 09/08/2024 | 97,33 | 100,76 | 95,27 | 100,16 | +3,34% | 5,64% | 132.900 |
| 08/08/2024 | 93,59 | 97,76 | 92,04 | 96,92 | +3,86% | 6,11% | 106.300 |
| 07/08/2024 | 100,00 | 102,04 | 93,02 | 93,32 | -5,78% | 9,02% | 159.000 |
| 06/08/2024 | 97,94 | 100,37 | 97,50 | 99,04 | +0,93% | 2,93% | 126.100 |
| 05/08/2024 | 90,29 | 98,44 | 90,29 | 98,13 | -2,06% | 9,03% | 193.200 |
| 02/08/2024 | 101,01 | 103,48 | 98,94 | 100,19 | -3,94% | 4,49% | 115.500 |
| 01/08/2024 | 108,42 | 108,98 | 103,67 | 104,30 | -4,30% | 4,90% | 113.100 |
| 31/07/2024 | 110,32 | 112,13 | 106,42 | 108,99 | -1,02% | 5,18% | 138.100 |
| 30/07/2024 | 109,80 | 111,06 | 106,54 | 110,11 | +1,25% | 4,12% | 188.800 |
| 29/07/2024 | 107,29 | 108,93 | 105,75 | 108,75 | +1,50% | 2,96% | 136.900 |